A
CYTK icon

AlphaQuest’s Cytokinetics CYTK Stock Holding History

AlphaQuest’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,224
Closed -$459K – 534
2025
Q4 		$459K Buy
7,224
+2,365
+49% +$147K 0.03% 895
2025
Q3 		$267K Sell
4,859
-60
-1% -$2.47K 0.02% 1235
2025
Q2 		$163K Sell
4,919
-1,731
-26% -$60.2K 0.02% 1239
2025
Q1 		$267K Buy
6,650
+5,514
+485% +$253K 0.03% 843
2024
Q4 		$53.4K Buy
1,136
+1,135
+113,500% +$58.9K 0.01% 1275
2024
Q3 		$53 Sell
1
-7,354
-100% -$410K ﹤0.01% 1833
2024
Q2 		$398K Buy
+7,355
New +$444K 0.05% 541

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AlphaQuest's CYTK Position: Q1 2026 in Review

AlphaQuest sold out of Cytokinetics (CYTK) in Q1 2026, closing a stake of 7,224 shares — an estimated $459K sold.

AlphaQuest first reported a position in CYTK in Q2 2024 and held it in 7 quarters. The position peaked at $459K in Q4 2025. 440 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • AlphaQuest reported no remaining Cytokinetics position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 7,224 Cytokinetics shares in Q1 2026, an estimated $459K.
  • AlphaQuest first reported a position in Cytokinetics in Q2 2024 and held it in 7 quarters.
  • AlphaQuest's Cytokinetics position peaked at $459K in Q4 2025.
  • 440 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.